Download PDF
Thromb Haemost 1999; 82(04): 1375-1376
DOI: 10.1055/s-0037-1614403
Letters to the Editor
Schattauer GmbH

Poor Recovery and Short Survival of Infused Factor X in a Case of Acquired Factor X Deficiency and Amyloidosis

E. M. Duncan
1   From the Division of Haematology, Institute of Medical and Veterinary Science, Adelaide, and Adelaide, Australia
,
J. Cole
1   From the Division of Haematology, Institute of Medical and Veterinary Science, Adelaide, and Adelaide, Australia
,
A. R. Clarkson
2   Dept of Renal Medicine, Royal Adelaide Hospital, Adelaide, Australia
,
J. V. Lloyd
1   From the Division of Haematology, Institute of Medical and Veterinary Science, Adelaide, and Adelaide, Australia
› Author Affiliations
Further Information

Publication History

Received 12 May 1999

Accepted 07 June 1999

Publication Date:
08 December 2017 (online)

Also available at
    Permissions and Reprints

 

 

  • References

  • 1 Furie B, Voo L, McAdam K, Furie BC. Mechanism of factor X deficiency in systemic amyloidosis. N Engl J Med 1981; 304: 827-30.
    CrossrefPubMedGoogle Scholar
  • 2 Greipp PR, Kyle RA, Bowie EJW. Factor X deficiency in amyloidosis: a critical review. Am J Haem 1981; 11: 443-50.
    PubMedGoogle Scholar
  • 3 Gloy J, Bohler J, Schollmeyer P, Pavenstadt H. Primary amyloidosis with severe nephrotic syndrome and acquired factor X deficiency. Nephrol Dialysis Transplant 1997; 12: 588-90.
    CrossrefPubMedGoogle Scholar
  • 4 Bohrer H, Waldherr R, Martin E, Linke RP, Lin J, Ziegler R, Ritz E, Nawroth PP. Splenectomy in an uraemic patient with acquired factor X deficiency due to AL amyloidosis. Nephrol Dialysis Transplant 1998; 13: 190-3.
    CrossrefPubMedGoogle Scholar
  • 5 Furie B, Greene E, Furie BC. Syndrome of acquired factor X deficiency and systemic amyloidosis. In vivo studies of the metabolic fate of factor X. N Engl J Med 1977; 297: 81-5.
    CrossrefPubMedGoogle Scholar